The impact of inflammatory milieu is supported by evidence that high intratumoral IL1-β and TNF-α were associated with poor response to neoadjuvant therapy, and high IL-8 and GM-CSF were predictive of tumor grade and size [59]. The gene discussed is IL1B; the disease is neoplasm.